A comparative study of glycemic control of continuous insulin infusion versus single dose sub cutaneous insulin glargine injection in the patients admitted to ICU

 

B Phaninder Reddy¹, D Bhargava^2*

 

¹Assistant Professor, Department of Medicine, RVM Medical College, Village Laxmakkapaly, Mdl Mulugu, Dist Siddipet, Telangana, INDIA.

²Assistant Professor, Department of Medicine, Viswabharathi Medical College and Hospital, Penchikalapadu, Kurnool, INDIA.

Email: bhargava.dinni@gmail.com

 

REFERENCES

1. International Diabetes Federation. Diabetes Atlas. 5th edn. Brussels: International Diabetes Federation, 2012.
2. Holst JJ, Vilsbøll T. Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings. Diabetes ObesMetab 2013;15:3-14.
3. National Diabetes Fact Sheet, 2011.http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Last accessed on February 14, 2014.
4. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi A. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982.
5. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care 2003; 26:1421-1426.
6. Clement S, Braithwaite SS, Magee, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27:553-591.
7. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35(Suppl) 1:S11-S63.
8. Capes SE, Hunt D, Malmberg K, Gerstein H. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355:773-778.
9. Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009; 37:3001-3009.
10. Vasan SK, Pittard AE, Abraham J, Samuel P, Seshadri MS, Thomas. Cause-specific mortality in diabetes: retrospective hospital based data from south India. J Diabetes 2012; 4:47-54.
11. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006;61:284-289
12. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471‑8.
13. Bosarge PL, Shoultz TH, Griffin RL, Kerby JD. Stress‑induced hyperglycemia is associated with higher mortality in severe traumatic brain injury. J Trauma Acute Care Surg 2015; 79:289‑94.
14. Kerby JD, Griffin RL, MacLennan P, Rue LW 3rd. Stress‑induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma. Ann Surg 2012; 256:446‑52.
15. Khan SA, Ibrahim MN, Anwar‑ul‑Haq. Frequency and mortality associated with hyperglycemia in critically ill children. J Coll Physicians Surg Pak 2015; 25:878‑81.
16. Krinsley JS. Moving closer to untangling a sweet web: Hyperglycemia, diabetic status, and mortality in the critically ill. Crit Care Med 2010; 38:295‑6.
17. Douketis J. Review: Stress hyperglycemia after ischemic stroke indicates a greater risk for death in patients without diabetes. ACP J Club 2002; 136:114.
18. NICE‑SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283‑97.
19. Cavalcanti AB, Silva E, Pereira AJ, Caldeira‑Filho M, Almeida FP, Westphal GA, et al. A randomized controlled trial comparing a computer‑assisted insulin infusion protocol with a strict and a conventional protocol for glucose control in critically ill patients. J Crit Care 2009; 24:371‑8.
20. Nichols R, Zawada E, Johnson T, Aaronson ML, Herr P, Casanova J, et al. Implementation of an insulin protocol using a multiplier‑based calculation for determining infusion rates in critically ill patients. S D Med 2008; 61:247, 249‑53.
21. Campbell RK, White JR, Levien T, Baker D. Insulin glargine. Clin Ther 2001; 23:1938‑57.
22. McKeage K, Goa KL. Insulin glargine: A review of its therapeutic use as a long‑acting agent for the management of type 1 and 2 diabetes mellitus. Drugs 2001; 61:1599‑624.